Pharmafile Logo
Pharmafocus logo
Advanced Search

dementia

Showing 15 posts of 63 posts found.

Vesper Bio reports positive topline results for dementia candidate

November 7, 2025
Research and Development Frontotemporal degeneration, Vesper Bio, clinical trials, dementia

Vesper Bio, a clinical-stage biotech developing novel oral therapies for neurodegenerative and neuropsychiatric disorders, has reported positive topline data from …

News
brain-770044_960_720

Lilly’s drug for early Alzheimer’s shows promising results

August 6, 2025
Medical Communications, Research and Development Alzheimer's, Eli Lilly, Neurology, dementia

Eli Lilly (Lilly) has announced positive new data from the long-term extension of its phase 3 study, showing that Kisunla …

News
Prescriptions image

Mental health medicine use in England reaches record high, NHSBSA report reveals

July 29, 2025
Manufacturing and Production, Medical Communications, Research and Development ADHD, COVID-19, NHS Business Services Authority, Psychiatry, antidepressants, antipsychotics, anxiolytics, barbiturate, dementia, hypnotics, mental health

According to new data published by the NHS Business Services Authority (NHSBSA), mental health prescriptions in England have reached their …

News
robina-weermeijer-ihfopazzjhm-unsplash_5

Eisai and EcoNaviSta enter dementia collaboration

July 25, 2024
Business Services EcoNaviSta, Eisai, Neurology, collaboration, dementia

Eisai and EcoNaviSta have announced that they have entered into a business alliance agreement, initiating their collaboration intended to build …

News
dementia image

Nxera Pharma partner Neurocrine Biosciences enters phase 1 NBI-1117567 study

May 9, 2024
Research and Development Alzheimer's disease, Neurocrine Biosciences, Neurology, Nxera Pharma, Parkinson's disease, clinical trials, dementia, schizophrenia

Nxera Pharma’s neuroscience-focused biopharmaceutical partner  Neurocrine Biosciences has announced it has successfully started its phase 1, first-in-human trial of investigational …

News

Otsuka and Lundbeck gain FDA approval for supplemental New Drug Application for dementia drug

May 11, 2023
Medical Communications FDA, Lundbeck, Neurology, Otsuka Pharmaceuticals, alzheimer's disease, dementia

Japan-based healthcare company Otsuka Pharmaceutical and Danish pharma company Lundbeck have announced that the US Food and Drug Administration (FDA) …

News
394px-ad_versus_co

New model can help predict cognitive decline in patients with Alzheimer’s

August 5, 2019
Sales and Marketing Alzheimer's pharma, cognitive decline, computing, dementia, pharma

Scientists at MIT have developed a new model which can predict whether patients at risk for Alzheimer’s disease will experience …

News
psm_v46_d168_mesial_view_of_the_human_brain

Novartis and Amgen halt trials into Alzheimer’s drug after patients get worse

July 12, 2019
Medical Communications Alzheimer's, Amgen, Banner Alzheimer's Institute, Novartis, dementia, pharma, research

Novartis, Amgen and Banner Alzheimer’s Institute have dropped a study into investigational Alzheimer’s drug CNP520 (umibecestat) after some patient’s conditions …

News

Pfizer supressed research suggesting arthritis drug Enbrel reduced risk of Alzheimer’s by 64%

June 6, 2019
Research and Development Alzheimer's, Drug therapy, Pfizer, dementia, pharma

Pfizer supressed data suggesting that their drug Enbrel reduced the risk of patients developing Alzheimer’s disease by 64%. In 2015, …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

May 3, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, Gilead, autism, dementia, opioids, pharma

This week was marked by the failure of two Phase 3 trials after both Eli Lilly and Gilead suffered from …

News
astrocyte5

Scientists identify new form of dementia

May 1, 2019
Research and Development AD, Alzheimer's, dementia, late, neuroscience

A team of scientists from Britain and the United States have described a new form of dementia, according to a …

News
blood-1813410_960_720

Heart drugs show promise in stroke and dementia

April 25, 2019
Research and Development angina, cilostazol, dementia, heart drugs, isosorbide mononitrate, stroke

Drugs for heart disease and angina have shown promise as preventative treatments for stroke and dementia, according to scientists from …

News
icl

Imperial College London researchers developing tech to monitor dementia patients at home

April 17, 2019
Research and Development dementia, imperial college london, pharma

Researchers at Imperial College London are hard at work developing technology to aid the lives of dementia patients in their …

News

Google accused of profiting from misleading dementia supplement ads

March 26, 2019
Manufacturing and Production Alzheimer's, dementia, google, pseudomedicine, search engines, tech

Google has been accused of profiting from false hope after running adverts for unproven dementia treatments which can cost as …

News

HIV drug holds hope for Alzheimer’s after significantly reducing inflammation in mice

February 7, 2019
Research and Development HIV, dementia, inflamation

Lamivudine, a generic drug for HIV, significantly reduces age-related inflammation and other signs of aging in mice, according to a …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026